Introduction: Therapeutic Plasma Exchange (TPE) is a procedure in which the patient's blood is passed through an apheresis machine, where the filtered plasma is removed and discarded with reinfusion of red blood cells along with replacement fluid such as plasma or albumin in to the patient. We present our experience with TPE in treatment of various neurologic and non-neurologic diseases.
Aim: To evaluate TPE as primary therapy or as a first-line adjunct to other initial therapies as mentioned by American Society for Apheresis (ASFA).
Materials and methods: A retrospective analysis of TPE procedures was done for a period of nine years, from January 2007 to May 2016 in a tertiary care teaching hospital. A total of 584 TPE procedures were performed in 161 patients between 2 to 75 years of age. Clinical and laboratory investigations like ECG, chest X-ray, cardiorespiratory status and serology were carried out before the TPE procedure.
Results: A total of 161 patients were enrolled in the present study. Guillain-Barre Syndrome (GBS) (67.7%, n=109) was the main indication for TPE, followed by Myasthenia Gravis (MG) (13.04%, n=21). Overall incidence of adverse reactions was 9.93%, inadequate vascular access was a common complication encountered in paediatric age group.
Conclusion: Our results show that TPE is not only safe and effective treatment alternative to Intravenous Immunoglobulin (IVIG), it also strongly holds evidence in the improvement of neurological disorders compared to non-neurological disorders. There is need of further detail evaluation on large number of cases for proper evidence based practice.
Keywords: Apheresis; Guillain-Barre syndrome; Myasthenia Gravis.
Therapeutic plasma exchange in pediatric patients of Guillain-Barre syndrome: Experience from a Tertiary Care Centre.Asian J Transfus Sci. 2016 Jan-Jun;10(1):98-100. doi: 10.4103/0973-6247.165834. Asian J Transfus Sci. 2016. PMID: 27011681 Free PMC article.
Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.Transfus Apher Sci. 2008 Apr;38(2):109-15. doi: 10.1016/j.transci.2007.11.002. Epub 2008 Mar 10. Transfus Apher Sci. 2008. PMID: 18331814 Clinical Trial.
Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.Indian J Hematol Blood Transfus. 2017 Mar;33(1):97-105. doi: 10.1007/s12288-016-0661-3. Epub 2016 Feb 22. Indian J Hematol Blood Transfus. 2017. PMID: 28194064 Free PMC article.
Therapeutic Plasma Exchange in Guillain-Barre Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.Presse Med. 2019 Nov;48(11 Pt 2):338-346. doi: 10.1016/j.lpm.2019.03.016. Epub 2019 Oct 31. Presse Med. 2019. PMID: 31679897 Review.
Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases.Transfus Apher Sci. 2007 Feb;36(1):103-7. doi: 10.1016/j.transci.2006.06.008. Epub 2007 Jan 16. Transfus Apher Sci. 2007. PMID: 17224307 Review.
Cited by 3 articles
Therapeutic Plasma Exchange: An Indispensable Therapy for Severe Neurological Condition.J Crit Care Med (Targu Mures). 2020 May 6;6(2):89-90. doi: 10.2478/jccm-2020-0021. eCollection 2020 Apr. J Crit Care Med (Targu Mures). 2020. PMID: 32426514 Free PMC article. No abstract available.
COVID-19: an update on diagnostic and therapeutic approaches.BMB Rep. 2020 Apr;53(4):191-205. doi: 10.5483/BMBRep.2020.53.4.080. BMB Rep. 2020. PMID: 32336317 Free PMC article.
Hemodynamic Collapse Following Therapeutic Plasma Exchange in a Patient Receiving an Angiotensin Receptor Blocker.Cureus. 2020 Feb 18;12(2):e7028. doi: 10.7759/cureus.7028. Cureus. 2020. PMID: 32211262 Free PMC article.